Facility Expansion Pace Life Sciences has recently expanded and remodeled its Salem, New Hampshire facility to establish a Center of Excellence for Aseptic Fill-Finish Processing, signaling capacity growth and a focus on aseptic capabilities that could benefit partners requiring scalable fill-finish services.

Strategic Partnerships The company is actively forming collaborations, such as with Cenevo for digital lab transformation, indicating openness to technology-enabled efficiency gains and external partnerships that could open co-development or CRO/CMO collaboration opportunities.

Industry Engagement Pace Life Sciences maintains an active presence at industry events and speakers engagements (SQA meetings, networking events, Life Sciences showcases), suggesting opportunities to connect with decision-makers, present capabilities, and generate new business leads.

Growth Readiness With revenue in the mid-range and a leadership expansion (Division President hired in 2024) alongside a nationwide network of CDMO/CRO sites, Pace appears positioned to scale services from early-phase R&D to commercial GMP support, presenting cross-sell potential across regulatory, QA, and manufacturing services.

Capability Spotlight A Center of Excellence for Aseptic Fill-Finish and ongoing lab/ GMP support across development stages highlight core competencies that align with customers seeking reliable aseptic manufacturing, fill-finish, and analytical GMP lab services, creating upsell opportunities to enhance existing customers’ development pipelines.